23 September 2020 | News
The patient-centric tools for rapid start-up and continual data flow improve patient engagement and data collection and allow sponsors to stay informed at every step with Sponsor visible portals
Photo Credit: Freepik
The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical has expanded its eclinical solutions offering, with advanced digital clinical tools for enhanced patient engagement, visibility, data capture, and analysis. www.avancecro.com/eclinical-solutions
Avance Clinical made the announcement at BioPharm America (September 21-24, 2020)
Avance Clinical’s biotech clients now have the option to deploy the latest eclinical solutions to maximise the value of study data and deliver real-time visibility on study progress.
Avance Clinical CEO Yvonne Lungershausen said, “Our Data Management team works with eClinical leaders such as Medrio to offer regulatory compliant and patient-centric tools for rapid start-up and continual data flow. These tools improve patient engagement and data collection and allow Sponsors to stay informed at every step with Sponsor visible portals.”
The Avance Clinical eclinical services include the following:
eSource
eConsent
ePRO
Glynn Morrish, Avance Clinical Director Biometrics said, “Direct electronic capture of study information and the complimentary suite of solutions offered by Avance Clinical allows the company and its clients to maximise clinical trial efficiency and flexibility while ensuring data integrity is preserved. Our highly trained and experienced biometrics team are excited to continue to work at the forefront of innovation and technology and provide services that offer stability and robustness to studies being conducted in an ever-changing global environment.”
Avance Clinical is an Australian owned Contract Research Organisation that has been providing high-quality clinical research services fit for global regulatory standards to the local and international drug development industry for 20 years.